Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-20

Clinical Trial Update: Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial update on the long-term safety of clopidogrel after drug-eluting stent implantation in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED